Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > Australian Nanotechnology Companies Set to Revoltionize Drug Delivery

Interstitial NanoSystems and Quintain NanoSystems Spin Off From NanoVic

Australian Nanotechnology Companies Set to Revoltionize Drug Delivery

MELBOURNE, AUSTRALIA and BOSTON, MA | Posted on May 7th, 2007

Two Australian bio-nanotech companies are set to revolutionize the way that medicine is delivered. Victorian Premier Steve Bracks announced today at BIO 2007 in Boston that Nanotechnology Victoria Ltd (NanoVic) is launching Interstitial NanoSystems (Interstitial NS) and Quintain NanoSystems (Quintain NS) as independent companies. The NanoVic spin-offs are the result of a portfolio of projects and developments built around strategic investment of nearly A$14 million with over a dozen partners since 2004.

Interstitial NanoSystems

Interstitial NS is initially focusing on its pain-free insulin delivery patch for diabetes, while the first product for Quintain NS is a rapid clinical test for the detection of meningitis. "Both diseases have devastating effects on people around the world," said Mr. Bracks. "Any new product that makes it easier to test for a disease or to take a life-saving drug is welcomed." NanoVic is attending BIO 2007 and will have prototypes of a selection of these products on display.

Dr. Bob Irving, Director of Interstitial NS and Quintain NS said, "We are excited at the prospects of the two new companies, Interstitial NS and Quintain NS, commercializing the nanotechnology innovations in delivery and diagnostics, to provide better health outcomes with reduced costs to the community. These companies will help to consolidate the key skills, technologies and manufacturing abilities in areas of nanomedicine, where Australia and Victoria have strength."

The Interstitial NS transdermal delivery patch for insulin has already been tested on animals by the Victorian College of Pharmacy and is expected to begin pre-clinical trials in September. Interstitial NS is working with Melbourne-based company Catapult to produce a portable prototype device to enable self administration. The patches are manufactured by the Victorian company MiniFAB, while the nanostructured drugs are formulated by Eiffel Technology.

Interstitial NS will also commercialize a device for pulmonary delivery of nanoparticulate drugs. The portable personal inhaler uses Surface Acoustic Wave (SAW) technology, with Melbourne-based Charlwood Design designing the prototype pump. Pre-clinical trials are anticipated to start in January 2008. The transdermal delivery technology used by Interstitial NS has already been recognized as "prime technological innovation" by analysts Frost & Sullivan.

Quintain NanoSystems

Quintain NS has a number of products in the pipeline, initially focusing on a diagnostic test for the detection of meningitis. The test uses nanoparticle technology to provide a rapid color-based readout, avoiding lengthy bacterial culturing for identifying the bacteria. Also in development are a number of other diagnostic tools. Nanoparticle-based imaging reagents will enable early detection of disease states in humans. Nanoarray biochips will offer a cost effective method of detection for both salmonella and bovine mastitis, and enzyme biosensor probes are under development for the measurement of sulfite in food and beverages.


About NanoVic
Nanotechnology Victoria Ltd is the key organization for delivering nanotechnology research outcomes to Victorian industry. NanoVic has a membership of three universities; Monash, RMIT and Swinburne as research and technology providers, with financial backing from the State Government of Victoria.

For more information, please click here

Media Contact:
Michelle Linn
Linnden Communications
Office: 508-419-1555
Mobile: 774-696-3803

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Nanometrics Announces Upcoming Investor Events November 18th, 2015

Harris & Harris Group Portfolio Company, D-Wave Systems, Announces Multi-Year Agreement With Lockheed Martin November 16th, 2015

Arrowhead Late-Breaking Clinical Data Shows that ARC-520 Can Produce Deep and Durable Reductions of Hepatitis B Viral Antigens and DNA November 16th, 2015

Harris & Harris Group Portfolio Company, D-Wave Systems, Announces the Sale of Its Latest Quantum Computer to Los Alamos National Laboratory November 11th, 2015


Nanoparticles simplify DNA identification and quantification November 27th, 2015

Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015

Electric fields remove nanoparticles from blood with ease November 24th, 2015

Production of Nanocapsules Containing Omega-3 Powder in Iran November 24th, 2015


Stanford technology makes metal wires on solar cells nearly invisible to light November 27th, 2015

Dimensionality transition in a newly created material November 27th, 2015

Nanoparticles simplify DNA identification and quantification November 27th, 2015

A new form of real gold, almost as light as air November 27th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic